Allscripts Appoints Vice President and Managing Director, EMEA

AllscriptsAllscripts (NASDAQ: MDRX) has appointed a new leader for its business in the UK while strengthening its focus on Europe, the Middle East and Africa. Richard Strong, who was Vice President, International Services, is taking up the new role of vice president and managing director, EMEA.

Strong said his first priorities for the coming year would be to increase the number of NHS trusts signed-up to deploy the Sunrise electronic patient record and to raise awareness of the capabilities of its dbMotion population health management solution.

He said he would also be looking to bring new clinical and departmental systems to the UK, while taking elements of the UK approach to the Middle East, where there is keen interest in population health management, as well as in administrative and clinical systems.

"Allscripts is well-established in the UK and popular with ourcustomers," he said. "I am looking forward to building onthe excellent work we have already achievedwithin the region with the Global Digital Exemplar programme in the UK and with customers that have benefited from our clinical wrap approach."

"I want more people to hear about what Allscripts has delivered at some of the top performing trusts in the United Kingdom, which use dbMotion to share information with GPs and explore population health management. As we develop our strategy for EMEA, I want more organisations to benefit from the solutions that we are already deploying across the UK."

Strong started his career in the NHS in London, where his work as a biomedical scientist drew him into the implementation of laboratory information systems. He went on to work for Siemens Healthcare Systems and then Cerner UK, where he played a key role in the implementation of electronic patient record systems in the capital, before becoming its director of European services.

He also worked in both UK and international roles for Dell, before joining Allscripts in 2016, to help grow its global ambitions.

Alan Fowles, President Allscripts International, said: "The creation of the new role of vice president and managing director, EMEA, shows our commitment to growing Allscripts as a global company."

"Richard's background in the health tech industry, and his deep understanding of the requirements of health and care organisations in the UK, across Europe, and in the Middle East makes him the ideal choice for the role, and we are confident that this will enable more organisations to benefit from Allscripts’ sector-leading solutions, knowledge and experience."

Allscripts' rapid expansion and high levels of customer satisfaction were recognised in a 2018 KLAS performance report on the European electronic record market, which noted that it had gone from one Sunrise customer in 2011 to eight when the report was written.

The company is currently running a clinical wrap campaign to support trusts that want to digitise without the cost and disruption caused by scrapping their existing patient administration systems and other IT investments.

This is in line with the NHS Long Term Plan’s recognition to complete the digitisation of hospitals through an extension of the GDE programme and an accelerated roll-out of EPRs. The plan also gave strong support to the development and deployment of population health management.

Some of the additional products that Allscripts will be bringing to the UK from other regions include Sunrise Surgical Care with iPro Anaesthesia, the Patient Flow with Census Logic hospital status application, and Follow My Health, a patient engagement platform, as well as integrated electronic document management.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

DigiConnect: e-healthcare - 24/7 Health …

Given the current outbreak of COVID-19, healthcare providers in the Middle East along with the rest of the world are currently putting relentless efforts to provide an innovative offering that...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...